DE NOVO THIRD PARTY HLA ANTIBODIES SYNERGIZE WITH DE NOVO DONOR SPECIFIC HLA ANTIBODIES TO NEGATIVELY IMPACT LUNG ALLOGRAFT OUTCOME

被引:0
|
作者
Zhang, Aiwen [1 ]
Good, Derek J. [1 ]
Thomas, Dawn M. [1 ]
Walendzik, Allison [1 ]
Cagahastian, Van [1 ]
Allen, Jeffrey [1 ]
McMichael, John [1 ]
McCurry, Kenneth [2 ]
Budev, Marie [2 ]
Gebel, Howard M. [3 ]
Bray, Robert A. [3 ]
机构
[1] Cleveland Clin, Allogen Labs, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
关键词
D O I
10.1016/j.humimm.2019.07.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OR25
引用
收藏
页码:32 / 33
页数:2
相关论文
共 50 条
  • [21] CORRELATION OF HLA ALLOEPITOPES WITH THE DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODIES AFTER RENAL TRANSPLANTATION
    Wiebe, Chris
    Blydt-Hansen, Tom
    Gibson, Ian
    Pochinco, Denise
    Rush, David
    Nickerson, Peter
    HUMAN IMMUNOLOGY, 2012, 73 : 101 - 101
  • [22] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [23] The natural history of de novo donor-specific HLA antibodies after kidney transplantation
    Lopez del Moral, Covadonga
    Wu, Kaiyin
    Naik, Marcel
    Osmanodja, Bilgin
    Akifova, Aylin
    Lachmann, Nils
    Stauch, Diana
    Hergovits, Sabine
    Choi, Mira
    Bachmann, Friederike
    Halleck, Fabian
    Schrezenmeier, Eva
    Schmidt, Danilo
    Budde, Klemens
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES ARE PREDICTIVE FOR REJECTION OF INTESTINAL AND MULTIVISCERAL TRANSPLANTS
    Lachmann, Nils
    Gerlach, Undine A.
    Todorova, Kremena
    Schulze, Harald
    Pascher, Andreas
    Schoenemann, Constanze
    TISSUE ANTIGENS, 2012, 79 (06): : 511 - 511
  • [25] Clinical relevance of de novo donor-specific HLA antibodies (DSA) in renal transplantation
    Sommer, Florian
    Kauke, Teresa
    Rueth, Stefan
    Anthuber, Matthias
    TRANSPLANTATION, 2016, 100 (07) : S615 - S615
  • [26] Association of intraindividual tacrolimus variability with the development of de novo donor-specific hla antibodies
    Fichtner, Alexander
    Schmidt, Jeremy
    Suesal, Caner
    Hoecker, Britta
    Rieger, Susi
    Vinke, Tobias
    Toenshoff, Burkhard
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [27] Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation
    Papachristou, M.
    Fylaktou, A.
    Daoudaki, M.
    Cholongitas, E.
    Karampatakis, T.
    Anastasiou, A.
    Chatzika, G.
    Makrovasili, F.
    Vagiotas, L.
    Karakasi, K.
    Fouzas, I.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (02) : 424 - 428
  • [28] ASSOCIATION OF INTRAINDIVIDUAL TACROLIMUS VARIABILITY WITH THE DEVELOPMENT OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES
    Alexander, Fichtner
    Claudia, Schroeder
    Caner, Suesal
    Britta, Hoecker
    Susanne, Rieger
    Tobias, Vinke
    Jens, Westhoff
    Rudiger, Waldherr
    Burkhard, Toenshoff
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1956 - 1956
  • [29] CLINICAL RELEVANCE OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES (DSA) IN RENAL TRANSPLANTATION
    Sommer, Florian
    Kauke, Teresa
    Anthuber, Matthias
    TRANSPLANT INTERNATIONAL, 2017, 30 : 356 - 356
  • [30] Histological Findings of Bronchial Biopsies and De Novo Donor Specific HLA Antibodies: Comparing Notes
    Askar, M.
    Reville, P.
    Klingman, L.
    Zhang, A.
    Schold, J.
    Daghstani, J.
    Budev, M.
    McCurry, K.
    Farver, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S169 - S169